Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
motexafin gadolinium thioredoxin reductase NA Successful target TTD , DGIDB Neoplasms[MeSHID:D009369]
Lymphoma[MeSHID:D008223]
Malignant neoplasm of lung[MeSHID:D008175]
Malignant neoplasm of brain[MeSHID:D001932]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
HIV Infections[MeSHID:D015658]
NA approved unknown
motexafin gadolinium ribonucleoside-diphosphate reductase subunit m2 small molecule NA drugbank , DGIDB Neoplasms[MeSHID:D009369]
Lymphoma[MeSHID:D008223]
Malignant neoplasm of lung[MeSHID:D008175]
Malignant neoplasm of brain[MeSHID:D001932]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
HIV Infections[MeSHID:D015658]
NA investigational unknown
motexafin gadolinium thioredoxin reductase 1, cytoplasmic small molecule NA drugbank , DGIDB Neoplasms[MeSHID:D009369]
Lymphoma[MeSHID:D008223]
Malignant neoplasm of lung[MeSHID:D008175]
Malignant neoplasm of brain[MeSHID:D001932]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
HIV Infections[MeSHID:D015658]
NA investigational unknown
motexafin gadolinium thioredoxin reductase 2, mitochondrial small molecule NA drugbank , DGIDB Neoplasms[MeSHID:D009369]
Lymphoma[MeSHID:D008223]
Malignant neoplasm of lung[MeSHID:D008175]
Malignant neoplasm of brain[MeSHID:D001932]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
HIV Infections[MeSHID:D015658]
NA investigational unknown
click here to return to the previous page